Pharm
Nifurtimox
search
Nifurtimox
, Lampit
See Also
African Trypanosomiasis
American Trypanosomiasis
NECT
Indications
African Trypanosomiasis
Used in
NECT
combination with
Eflornithine
American Trypanosomiasis
(
Chagas Disease
, T. cruzi)
FDA approved in U.S. for use in children age <18 years (and at least 2.5 kg)
Contraindications
Pregnancy
Mechanism
Nitrofuran derivative with
Antiprotozoal
activity
Nifurtimox is cytotoxic to targeted
Protozoa
Nifurtimox is reduced by
Protozoa
l enzymes to a free radical, triggering cytotoxic superoxide anion (02-)
Superoxides alkylate parasitic
Nucleic Acid
s and
Protein
s, disrupting
Protozoa
l
Cell Structure
and function
Medications
Tablets: 30 mg, 120 mg
Dosing
American Trypanosomiasis
(age <18 years)
Gene
ral
Avoid in weight <2.5 kg
Dose to closest available 1/2 tablet
Weight <41 kg
Give 10-20 mg/kg DIVIDED three times daily orally with food for 60 days
Weight >41 kg
Give 8-10 mg/kg DIVIDED three times daily orally with food for 60 days
Dosing
West
African Trypanosomiasis
See
Eflornithine
See
African Trypanosomiasis
Eflornithine
renal dose adjustment needed for eGFR <30 ml/min
NECT
(
Eflornithine
/Nifurtimox)
Indications
Severe Stage 2 West
African Trypanosomiasis
with
CSF Leukocyte
s >100 wbc/uL (any age)
Dosing
Eflornithine
400 mg/kg/day IV divided every 12 hours for 7 days AND
Nifurtimox 15 mg/kg/day divided every 8 hours for 10 days
Adverse Effects
Gastrointestinal
Decreased appetite
Nausea
and
Vomiting
Abdominal Pain
Miscellaneous
Headache
Fever
Rash
Safety
Pregnancy
Avoid in pregnancy based on animal studies (
Miscarriage
,
IUGR
risk, skeletal malformations)
Lactation
Is present in
Breast
milk (at <15% of the recommended pediatric dose), with no reported adverse effects
Monitor for decreased oral intake,
Vomiting
, rash, fever and irritability
Resources
Dailymed (Nifurtimox)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90d09714-a8b1-4696-8ada-f99dc54d0721#ID_e21d6b64-015f-4fb9-ad6c-fd51c016c53b
Type your search phrase here